Trial intelligence / Profile preview

CFR Quantification by Stress Perfusion MRI

NCT01655043Phase 2Completed

Sponsor
Northwestern University
Start
Sep 2012
Primary completion
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gadofosveset in coronary artery disease (CAD), sponsored by Northwestern University. Started Sep 2012; status: completed.

02

Drugs

gadofosveset
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01655043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01655043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call